Why Employers Are Zeroing In On GLP-1s The numbers tell the story: 40% of US adults are living with obesity, with projections closer to 50% by 2030 Employers spend $6,472 more per year on employees with obesity than on healthy-weight employees across medical, productivity, disability, and workers comp Individuals who use GLP-1s can lose between 2.5% and 20% of their initial body weight when taking the medication as instructed Employers want to support prevention, not wait until employees are sicker to qualify for care
Are you willing to work through initial side effects
NAEs were identified using SOC = nervous system disorders (SOC ID: 10,029,205) and primary SOC = Yes, encompassing 1075 PTs from MedDRA version 27.0
What if you miss a dose of Fluoxetine HCl
For those following metabolic peptide research, retatrutide represents a significant step forward in multi-target approaches to body composition and metabolic health
The only safe and legal way to obtain retatrutide is through clinical trials, and any website or individual claiming to sell it outside of a trial is not offering a legitimate product